Fundamental,Technical & buy indicators looking strong3 Sep 2025 02:26
The tide has turned fundamental & technical indicators are all now pointing to a strong uptrend and hemogenyx is now a strong buy. So I'm staying long and not selling any shares.
Over the last 4 to 5 years the doomsdayers always used funding as a tool to spread so much negative nonsense knowing this will install fear into LTH and discourage new investors, over the last 4 to 5 years bringing the shareprice to it's knees, however the tide has changed now big time and I'm so pleased we have attracted funding from a small group of "DEDICATED INVESTORS" YES dedicated investors at a "PREMIUM" YES a premium to the market price. This reflects investors' confidence in the progress made, they must understand all the positives to willingly want to invest large sums of money 💰
As we are about to soon get a major RNS update on p1, p2 & possibly p3 progress this will be a massive achievement moment for Hemogenyx. And for any new investors looking to jump on board this amazing opportunity all I say is look at the facts and let the facts do the talking look at the history over the last 18 months look at the RNS'S over the last 18 months there is no way the shareprice should not be this low now 720 odd (1.8p old money) this is nothing absolute peanuts the shareprice should be a lot lot higher.
Look at all the positives regarding Hemogenyx Pharmaceuticals over the last 18 months All ready done the following:
. New breed of strong cash rich investors with deep pockets & power backing HEMO 💪
. Next will advance to the 2nd adult dose cohort at twice the initial dose
· Initiate recruitment for the pediatric arm of the trial, addressing a critical unmet need in childhood AML.
.1st 2 patients treated with HG-CT-1 remain alive at 6 & 3 months post-treatment, respectively.
. 3rd & final patient has been successfully treated completing the 1st adult dose cohort
. Extra Clean room now ready for "Cash generative" 3 pronged pipeline approach
. Hemogenyx Awarded Grant (+ more 2 come)
. Streamlined cutting overhead cost approach means less funds needed going forward.
. Clearance to Proceed with Pediatric Expansion
. 2nd Patient Treated with HG-CT-1 CAR-T Therapy
. 1st Patient Treated with HG-CT-1 CAR-T Therapy
. 1st-in-Human Treatment with HG-CT-1 Clearance
. Opening of First Clinical Site
. IRB Approval for Phase I Clinical Trial
. CBR Brain Delivery
. CBR Intranasal Delivery
. FDA granted approval ( this is a massive achievement)
All of the above achieved in the last 18 months come on that some amazing work ok funding was needed along the way, however the business model is now changed grant's coming in as a few Patients treated and doing OK, cutting back on unnecessary salaries and Clean room will become cash generative. So yes it's all beginning to come together nicely now as hemogenyx beginning to rubs shoulders with the big boys...
Sign In
Follow the stocks
